Integrated demonstration
Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.
Load EXP-0885 · Site E · 15 November 2026Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.
Which intelligence is being demonstrated?
- Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
- Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
- Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
- Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads
Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.
- Direct entry with mobile-friendly forms and future offline capabilities.
- Validated CSV/Excel imports with schema, chronology and data-quality checks.
- Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.
Programme dashboard
Screening activity and follow-up across the synthetic programme.
Programme activity
- Unique participants screened
- 7
- Screening encounters
- 7
- Diagnostic referrals
- 0
- Outstanding pathways
- 0
Screening pathway
- Screening7Encounters
- Positive finding0Documented findings
- Referral0Diagnostic referrals
- Follow-up0Diagnostic visits
- Outcome0Resolved pathways
Stage totals use different units. Pending pathways: 0. Insufficient observation: 0.
Participant insight
Expanded synthetic participant 2980 · EXP-2980Synthetic · Site E
Full participant history through 2025-01-01, across modalities and pathways.
- · Screening · HPV DNA · Initial · Programme entry
Referral-time risk
No matching referral was available at this observation date.
Screened participants
7 matching participants. Select a participant to review their timeline and referral-time risk.
| Participant | Site |
|---|---|
| EXP-0124 · Expanded synthetic participant 0124 | Site D — Community Engagement Programme |
| EXP-0893 · Expanded synthetic participant 0893 | Site A — Urban Referral Hub |
| EXP-1471 · Expanded synthetic participant 1471 | Site A — Urban Referral Hub |
| EXP-2848 · Expanded synthetic participant 2848 | Site A — Urban Referral Hub |
| EXP-2980 · Expanded synthetic participant 2980 | Site E — Resource-Constrained Navigation Programme |
| EXP-3663 · Expanded synthetic participant 3663 | Site C — Rural Outreach Programme |
| EXP-4281 · Expanded synthetic participant 4281 | Site B — Peri-Urban Access Programme |
Programme insights
Encounters by modality
- VIA
- 2
- HPV DNA
- 4
- Cytology
- 1
Navigation activity
- Barrier documented
- 0
- Contact attempt
- 0
- Navigation intervention
- 0
- Diagnostic booking
- 0
- Diagnostic visit
- 0
Documented barriers
- Contact difficulty
- 0
- Transport difficulty
- 0
- Appointment coordination
- 0
Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.